CCM
CNMD icon

Cadence Capital Management’s CONMED CNMD Stock Holding History

Cadence Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-74,750
Closed -$3.3M – 550
2014
Q2 		$3.3M Sell
74,750
-15,805
-17% -$717K 0.16% 249
2014
Q1 		$3.94M Sell
90,555
-79,096
-47% -$3.52M 0.17% 249
2013
Q4 		$7.21M Sell
169,651
-123,910
-42% -$4.71M 0.27% 110
2013
Q3 		$9.97M Sell
293,561
-56,517
-16% -$1.84M 0.34% 75
2013
Q2 		$10.9M Buy
+350,078
New +$11.4M 0.51% 38

Other funds holding CNMD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cadence Capital Management's CNMD Position: Q3 2014 in Review

Cadence Capital Management sold out of CONMED (CNMD) in Q3 2014, closing a stake of 74,750 shares — an estimated $3.3M sold.

Cadence Capital Management first reported a position in CNMD in Q2 2013 and held it in 5 quarters. The position peaked at $10.9M in Q2 2013. 164 funds tracked by Wall St. Rank hold CNMD as of Q3 2014.

  • Cadence Capital Management reported no remaining CONMED position as of Q3 2014 after selling out during the quarter.
  • Cadence Capital Management sold 74,750 CONMED shares in Q3 2014, an estimated $3.3M.
  • Cadence Capital Management first reported a position in CONMED in Q2 2013 and held it in 5 quarters.
  • Cadence Capital Management's CONMED position peaked at $10.9M in Q2 2013.
  • 164 funds tracked by Wall St. Rank held CONMED as of Q3 2014.

Based on Cadence Capital Management's 13F filing for Q3 2014, filed 3 Nov 2014.